SAI LIFE SCIENCES LIMITED (SAILIFE) Share Price Rises 3.06% Today
- August 20, 2026
- Posted by: Harsh Piplani
- Category: News
SAI LIFE SCIENCES LIMITED at Rs 1,465.75 rose 3.06% today; market capitalisation stood at Rs 30,544.5 crore as the healthcare stock entered the top-gainer list.
SAI LIFE SCIENCES LIMITED Share Price traded at Rs 1,465.75 on 20 August 2026, up Rs 43.55 or 3.06% from the previous close of Rs 1,422.20, taking the company’s market capitalisation to Rs 30,544.5 crore. That made SAI LIFE SCIENCES LIMITED Share Price one of the notable names in Stock Market Today and placed the healthcare counter among the session’s top gainers.
The supplied data confirms the price rise and shows why the stock is trending in today’s market update. The move began above the previous close, with the stock opening at Rs 1,445.55, then extending to an intraday high of Rs 1,468.70 before holding near that range at the time of the event. Intraday low levels remained at Rs 1,437.00, which means the session stayed positive through most of the observed range.
For investors searching SAI LIFE SCIENCES LIMITED Share Price Today, SAI LIFE SCIENCES LIMITED Stock News or why the stock is rising today, the verified takeaway is straightforward: the stock recorded a qualifying same-day gain under the Large Cap category. The supplied data confirms the event but does not establish a company-specific catalyst. What investors can monitor next is whether the price action continues to hold near the day’s upper band, whether volume participation remains supportive, and how the company compares with its healthcare sector and listed peers. Across this SAI LIFE SCIENCES LIMITED Share Price analysis, Univest focuses on what the data shows rather than on unsupported explanations.
SAI LIFE SCIENCES LIMITED (SAILIFE) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,465.75 |
| Previous Close | Rs 1,422.2 |
| Today's Change | +Rs 43.55 (+3.06%) |
| Day Open | Rs 1,445.55 |
| Day High | Rs 1,468.7 |
| Day Low | Rs 1,437 |
| Current Volume (BSE) | 10,193 |
| BSE Traded Volume | 10,193 |
| NSE Traded Volume | 2,15,451 |
| Combined NSE + BSE Volume | 2,25,644 |
| Turnover | Rs 1.49 crore |
| Market Capitalisation | Rs 30,544.5 crore |
| Market Cap Category | Large Cap |
SAI LIFE SCIENCES LIMITED (SAILIFE) traded at Rs 1,465.75. versus the previous close of Rs 1,422.2, a rise of 3.06%. The stock opened at Rs 1,445.55, reached Rs 1,468.7, touched Rs 1,437. Reported volume was 10,193.
SAI LIFE SCIENCES LIMITED (SAILIFE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 30,544.5 crore |
SAI LIFE SCIENCES LIMITED Fundamental Analysis begins with scale. At Rs 30,544.5 crore, the company’s market capitalisation places it far above the median and average market-cap figures supplied for the Healthcare benchmark universe. The same-sector benchmark covers 196 companies, where median market capitalisation is Rs 135.91 crore, average market capitalisation is Rs 467.67 crore, the minimum is Rs 3.67 crore and the maximum is Rs 3,012.78 crore. On those numbers alone, SAI LIFE SCIENCES LIMITED Share Price is attached to a business that screens much larger than the benchmark distribution shown here.
That size context matters in SAI LIFE SCIENCES LIMITED Stock Analysis because large-cap moves are usually read differently from gains in smaller counters. A 3.06% same-day price rise in a Rs 30,544.5 crore company is often watched closely because it combines liquidity, visibility and sector relevance. The supplied data does not include earnings, EPS, book value, dividend yield, ROE, ROCE, P/E, P/B, EV/EBITDA, leverage or cash-flow figures for the company itself, so the most reliable fundamental context comes from company size and relative market standing inside Healthcare.
For investors following SAI LIFE SCIENCES LIMITED Share News and SAI LIFE SCIENCES LIMITED Financial Results queries, today’s move is therefore more about market action than about a verified financial trigger. Still, market capitalisation itself provides a useful anchor: SAI LIFE SCIENCES LIMITED Share Price is being repriced within a relatively large listed healthcare company rather than a narrowly traded outlier. That is why the stock has entered the conversation in Stocks in News and Market Movers today. As Univest notes, the next step is to study how this market-cap profile fits with sector valuation ranges and how the company compares with its listed peers on the figures that are available.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Benchmark Median P/E | 26.32x |
| Benchmark Average P/E | 61.3x |
| Benchmark P/E Range | 2.76x to 1,607.56x |
| Benchmark Median P/B | 1.9x |
| Benchmark Median ROE | 11.12% |
| Benchmark Median ROCE | 13.35% |
| Company Market Capitalisation | Rs 30,544.5 crore |
| Benchmark Median Market Cap | Rs 135.91 crore |
SAI LIFE SCIENCES LIMITED (SAILIFE) is classified under sector: Healthcare.
Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.
SAI LIFE SCIENCES LIMITED operates in the Healthcare sector, and the sector snapshot offers an important benchmark for understanding why SAI LIFE SCIENCES LIMITED Share Price is being watched. The benchmark scope is the same sector and covers 196 companies, giving investors a broad cross-section of valuation, profitability and market-cap numbers across healthcare names.
On valuation, the Healthcare benchmark has 157 companies with P/E data. The median P/E is 26.32, the average is 61.3, the minimum is 2.76 and the maximum is 1,607.56. For P/B, 195 companies are covered, with a median of 1.9, an average of 2.61, a minimum of -13.33 and a maximum of 16.47. Profitability ranges are also wide: ROE data for 195 companies shows a median of 11.12% and an average of 15.66%, while ROCE data for 195 companies shows a median of 13.35% and an average of 17.87%.
These sector numbers tell investors that Healthcare is not a narrow valuation bucket. It includes companies priced near low-single-digit earnings multiples and others trading at extremely elevated multiples, alongside a broad spread in balance-sheet valuation and capital efficiency. That breadth is relevant for SAI LIFE SCIENCES LIMITED Share Price Today because it means the market often differentiates sharply between sub-segments, business models and profitability profiles within the same sector.
The market-cap distribution is similarly skewed lower than SAI LIFE SCIENCES LIMITED. In this benchmark, the maximum market capitalisation shown is Rs 3,012.78 crore, far below SAI LIFE SCIENCES LIMITED’s Rs 30,544.5 crore. That gap underlines how unusually large the company is relative to the listed sample supplied here. In Univest’s reading, that does not by itself make the stock expensive or inexpensive, but it does mean the stock’s price action deserves attention because it is taking place in a company with a much larger capital base than the sector comparables presented.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 3,012.78 | 48.9 | 1.87 | -0.78 | 8.31 |
| Hikal Ltd. | HIKAL | 2,679.94 | 0 | 2.22 | 15.22 | 16.15 |
| Dishman Carbogen Amcis Ltd. | DCAL | 2,648.85 | 167.12 | 0.41 | -2.89 | -0.26 |
| Solara Active Pharma Sciences Ltd. | SOLARA | 2,641.96 | 0 | 2.08 | 17.23 | 15.34 |
| Beta Drugs Ltd. | BETA | 2,610.72 | 64.32 | 10.17 | 18.65 | 22.17 |
SAI LIFE SCIENCES LIMITED (SAILIFE) has a market capitalisation of Rs 30,544.5 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
SAI LIFE SCIENCES LIMITED Share Price is also attracting attention because the company’s size stands out sharply against the listed peers supplied. Ind-Swift Laboratories Ltd. has a market capitalisation of Rs 3,012.78 crore, Hikal Ltd. Rs 2,679.94 crore, Dishman Carbogen Amcis Ltd. Rs 2,648.85 crore, Solara Active Pharma Sciences Ltd. Rs 2,641.96 crore and Beta Drugs Ltd. Rs 2,610.72 crore. Dr Agarwals Eye Hospital Ltd. stands at Rs 2,569.06 crore, Panacea Biotec Ltd. at Rs 2,488.01 crore, Venus Remedies Ltd. at Rs 2,417.29 crore, Sai Parenteral’s Ltd. at Rs 2,392.53 crore and Fredun Pharmaceuticals Ltd. at Rs 2,386.28 crore. Against that entire peer set, SAI LIFE SCIENCES LIMITED at Rs 30,544.5 crore is dramatically larger.
Valuation and profitability metrics across these peers show a wide spread. Ind-Swift trades at 48.9 times earnings with P/B of 1.87, ROE of -0.78% and ROCE of 8.31%. Dishman Carbogen Amcis is at P/E 167.12 and P/B 0.41 with ROE of -2.89% and ROCE of -0.26%. Beta Drugs shows P/E 64.32 and P/B 10.17, with ROE at 18.65% and ROCE at 22.17%. Dr Agarwals Eye Hospital has P/E 33.71, P/B 6.95, ROE 36.29% and ROCE 42.4%, making it one of the strongest profitability names in the supplied list.
Among the other peers, Hikal has P/B 2.22, ROE 15.22% and ROCE 16.15%; Solara has P/B 2.08, ROE 17.23% and ROCE 15.34%; Panacea Biotec has P/B 2.95, ROE 0% and ROCE 5.36%; Venus Remedies trades at P/E 20.4 and P/B 3.45 with ROE 9.85% and ROCE 7.89%; Sai Parenteral’s is at P/E 167.39 and P/B 3.06 with ROE 13.9% and ROCE 12.97%; and Fredun trades at P/E 53.77 and P/B 8.03 with ROE 11.42% and ROCE 13.15%.
Instead, the listed peer set shows that healthcare stocks can command very different multiples and generate very different return profiles. That makes today’s SAI LIFE SCIENCES LIMITED Share Price Update especially notable: investors are watching a much larger company than the peers listed, within a sector where pricing and profitability dispersion is exceptionally wide. Univest therefore reads the move as one that merits tracking through both scale and comparative market context.
Why Investors Are Watching SAI LIFE SCIENCES LIMITED
SAI LIFE SCIENCES LIMITED Share Price is in focus because today’s 3.06% gain was large enough to qualify as a market event in its own category, while the company’s Rs 30,544.5 crore market capitalisation gives the move broader relevance than a routine fluctuation in a smaller stock. For readers scanning Top Gainers Today, SAI LIFE SCIENCES LIMITED Stock News and Stocks Rising Today, the stock combines size, positive price action and active exchange participation across NSE and BSE.
- Verified price action: the stock rose from Rs 1,422.20 to Rs 1,465.75, with an intraday band of Rs 1,437.00 to Rs 1,468.70.
- Trading activity: total volume reached 2,25,644 shares, with 2,15,451 on NSE and 10,193 on BSE; turnover was Rs 1.49 crore.
- Market-cap context: SAI LIFE SCIENCES LIMITED is classified as Large Cap, and the day’s move cleared the event bar for that category.
- Sector positioning: the stock sits in Healthcare, where benchmark valuation and profitability ranges are unusually wide.
- Peer backdrop: the company’s Rs 30,544.5 crore market cap is far above the listed peer set supplied in the dataset.
The next things to monitor are straightforward: whether SAI LIFE SCIENCES LIMITED Share Price continues to hold near the upper end of today’s range, whether trading participation remains broad-based, and whether market attention deepens through sector and peer comparisons. As Univest highlights, the current data confirms the price event clearly, while any company-specific explanation would require further verified disclosures.
About SAI LIFE SCIENCES LIMITED
SAI LIFE SCIENCES LIMITED is presented in the supplied market data as a Healthcare company. The nearest industry references in the peer and benchmark set cluster around Pharmaceuticals & Drugs, with one hospital-services peer also present, which places the stock within a healthcare ecosystem where investors often compare businesses across drug development, manufacturing and related healthcare activities.
Even without a detailed company description in the supplied dataset, the market context is useful. SAI LIFE SCIENCES LIMITED Share Price is linked to a company with large listed scale relative to the healthcare comparison set provided here. That alone means it can attract attention not only from traders looking at Price Action and Momentum Analysis, but also from investors screening for large healthcare names within NSE News and BSE News.
The peer universe around it includes Ind-Swift Laboratories, Hikal, Dishman Carbogen Amcis, Solara Active Pharma Sciences, Beta Drugs, Panacea Biotec, Venus Remedies and Fredun Pharmaceuticals, most of which sit in Pharmaceuticals & Drugs. That suggests the market may often assess SAI LIFE SCIENCES LIMITED Share Price against a broader pharma-oriented backdrop when discussing sector valuation, market capitalisation and stock performance. In Univest coverage, this company context matters because it frames today’s gain within a listed healthcare segment that features broad differences in valuation, return ratios and company size.
Track SAI LIFE SCIENCES LIMITED Share Price on Univest
Use SAI LIFE SCIENCES LIMITED (SAILIFE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.
Users following SAI LIFE SCIENCES LIMITED Share Price can track the stock on Univest for live share price moves, day range changes, market capitalisation updates and broader stock analysis. Univest also helps readers place SAI LIFE SCIENCES LIMITED Share Price Today in context with sector benchmarks, peer comparison, 52-week tracking modules, shareholding pattern pages when available, and ongoing market insights built around verified data.
For investors searching SAI LIFE SCIENCES LIMITED Latest News, SAI LIFE SCIENCES LIMITED Company News or SAI LIFE SCIENCES LIMITED Share Price Live, Univest offers a structured way to monitor both market moves and comparative context across the Indian Stock Market. The goal is not to issue a recommendation, but to make SAI LIFE SCIENCES LIMITED Stock News easier to interpret through factual price, volume and sector analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is SAI LIFE SCIENCES LIMITED Share Price Today?
Ans. SAI LIFE SCIENCES LIMITED Share Price Today was Rs 1,465.75 at the captured event time. The stock was up Rs 43.55, or 3.06%, from the previous close of Rs 1,422.20 in today’s session.
Why is SAI LIFE SCIENCES LIMITED rising today?
Ans. The supplied data confirms that SAI LIFE SCIENCES LIMITED rose 3.06% in a qualifying same-day move for its Large Cap category. It shows the price event clearly, but it does not establish a company-specific catalyst.
What were the day high and day low for SAI LIFE SCIENCES LIMITED?
Ans. In today’s session, SAI LIFE SCIENCES LIMITED traded between a day low of Rs 1,437.00 and a day high of Rs 1,468.70. The stock was later seen at Rs 1,465.75, close to the session’s upper end.
How much did SAI LIFE SCIENCES LIMITED gain compared with the previous close?
Ans. SAI LIFE SCIENCES LIMITED gained Rs 43.55 over its previous close of Rs 1,422.20. In percentage terms, that translated into a 3.06% rise, making it one of the market’s notable top gainers today.
What was the opening price of SAI LIFE SCIENCES LIMITED today?
Ans. SAI LIFE SCIENCES LIMITED opened at Rs 1,445.55 today. Because that was above the previous close of Rs 1,422.20, the stock started the session on a positive note before moving toward Rs 1,468.70.
What is the market capitalisation of SAI LIFE SCIENCES LIMITED?
Ans. The market capitalisation of SAI LIFE SCIENCES LIMITED stood at Rs 30,544.5 crore in the supplied data. That places the company in the Large Cap category and makes today’s move relevant at a larger market scale.
How active was trading in SAI LIFE SCIENCES LIMITED today?
Ans. Trading activity was spread across both exchanges. NSE volume stood at 2,15,451 shares, BSE volume was 10,193 shares, and total volume reached 2,25,644 shares, while turnover was reported at Rs 1.49 crore.
Which sector does SAI LIFE SCIENCES LIMITED belong to?
Ans. SAI LIFE SCIENCES LIMITED belongs to the Healthcare sector in the supplied dataset. The sector benchmark covers 196 companies, giving investors a broad comparison set for valuation ranges, profitability metrics and market-cap positioning.
How does SAI LIFE SCIENCES LIMITED compare with the sector on size?
Ans. SAI LIFE SCIENCES LIMITED is much larger than the supplied Healthcare benchmark distribution. Its market capitalisation is Rs 30,544.5 crore, versus sector median market cap of Rs 135.91 crore and average of Rs 467.67 crore.
Why are investors tracking SAI LIFE SCIENCES LIMITED Stock News today?
Ans. Investors are tracking SAI LIFE SCIENCES LIMITED Stock News because the stock rose 3.06% in a Large Cap qualifying event, traded near its day high, and did so in a healthcare company far larger than listed peers supplied.
